Reports for TEVA CANADA LIMITED

Formerly known as ACTAVIS PHARMA COMPANY

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

214 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

2706 (92%)

2930

Discontinuation Reports

To be discontinued:

2 (1%)

Discontinued:

298 (99%)

Reversed:

0 (0%)

300

363 (11%)

103 (48%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-PROPRANOLOL 40MG TABLET Resolved 2020-04-10 2020-05-21 111835
TEVA-PROPRANOLOL 40MG TABLET Resolved 2022-09-07 2023-01-12 168741
TEVA-PROPRANOLOL 80MG TABLET Resolved 2023-06-20 2023-07-05 195760
TEVA-PROPRANOLOL 20MG TABLET Resolved 2025-03-27 2025-04-24 253565
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-13 2017-10-10 1778
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-05-02 2025-05-02 256462
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2020-05-01 2020-05-21 113761
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-12-17 2021-01-21 130291
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-21 2023-08-18 199554
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2025-02-20 2025-04-10 250906
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-05-02 2025-05-08 256465
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2019-09-12 2019-10-04 93656
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-02-06 2025-05-08 249731
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-07-05 195118
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-25 2021-04-21 136341
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-03-06 2020-05-21 107986
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-10 2020-06-04 111826
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-10 2020-05-29 111823
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2025-04-02 2025-04-10 253963
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-08 2023-07-12 194163
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-ATORVASTATIN 40MG TABLET Discontinued 2018-10-17 2018-10-17 64541
TEVA-ATORVASTATIN 10MG TABLET Discontinued 2018-10-17 2018-10-17 64606
TEVA-AZITHROMYCIN 250MG TABLET Discontinued 2025-04-25 2025-04-25 255821
TEVA-CARBAMAZEPINE 200MG TABLET Discontinued 2017-06-27 2017-06-27 14052
TEVA-CEPHALEXIN 250MG TABLET Discontinued 2020-10-08 2020-10-09 125982
TEVA-CEPHALEXIN 500MG CAPSULE Discontinued 2020-10-08 2020-10-09 125979
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64544
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64553
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64550
TEVA-CIPROFLOXACIN Discontinued 2018-10-12 2018-10-12 63952
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64547
TEVA-CIPROFLOXACIN 500MG TABLET Discontinued 2017-06-27 2017-06-27 14049
TEVA-CLARITHROMYCIN 500MG TABLET Discontinued 2020-06-11 2020-06-11 117526
TEVA-CLARITHROMYCIN 250MG TABLET Discontinued 2020-06-11 2020-06-11 117529
TEVA-CLOBETASOL 0.05% LOTION Discontinued 2025-04-25 2025-04-25 255815
TEVA-CLONAZEPAM 0.5MG TABLET Discontinued 2018-10-19 2018-10-19 64926
TEVA-CLONAZEPAM 0.5MG TABLET Discontinued 2018-10-19 2018-10-19 64923
TEVA-CLONAZEPAM 2MG TABLET Discontinued 2018-10-19 2018-10-19 64929
TEVA-DEFERASIROX 250MG TABLET FOR SUSPENSION Discontinued 2020-01-21 2020-01-21 103796
TEVA-DEFERASIROX 125MG TABLET FOR SUSPENSION Discontinued 2020-01-21 2020-01-21 103791

Showing 141 to 160 of 300